DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Symlin (Pramlintide Subcutaneous) - Wrong Technique in Drug Usage Process - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Wrong Technique in Drug Usage Process (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Symlin (Pramlintide Subcutaneous) where reactions include wrong technique in drug usage process. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Symlin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-04-18

Patient: female

Reactions: Wrong Technique in Drug Usage Process, Loss of Consciousness

Drug(s) suspected as cause:
Symlin

Other drugs received by patient: Novolog; Lantus



Possible Symlin side effects in 49 year old female

Reported by a consumer/non-health professional from United States on 2012-01-18

Patient: 49 year old female, weighing 179.2 kg (394.2 pounds)

Reactions: Perfume Sensitivity, Abdominal Pain, Agitation, Asthma, Wrong Technique in Drug Usage Process, Drug Ineffective, Unresponsive To Stimuli, Pain, Weight Increased, Overdose, Glycosylated Haemoglobin Increased, Dizziness, Depression, Pneumonia, Vomiting, Hyperglycaemia, Hypotension, Hernia Repair, Drug Prescribing Error, Respiratory Distress, Blood Glucose Decreased, Dysstasia, Urine Ketone Body Present, Suicide Attempt, Abscess, Sluggishness, Cardiac Arrest, Needle Issue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Symlin
    Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-12-21

Symlin
    Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
    Indication: Type 1 Diabetes Mellitus
    Start date: 2011-12-21

Symlin
    Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
    Indication: Type 2 Diabetes Mellitus
    Start date: 2005-12-01
    End date: 2005-12-01

Symlin
    Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
    Indication: Type 1 Diabetes Mellitus
    Start date: 2005-12-01
    End date: 2005-12-01

Symlin
    Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
    Indication: Type 2 Diabetes Mellitus
    End date: 2011-09-01

Symlin
    Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
    Indication: Type 1 Diabetes Mellitus
    End date: 2011-09-01

Symlin
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-09-01
    End date: 2011-12-20

Symlin
    Indication: Type 1 Diabetes Mellitus
    Start date: 2011-09-01
    End date: 2011-12-20

Other drugs received by patient: Insulin; Novolog; Mucinex; Synthroid; Prozac; Humulin U; Advair Diskus 100 / 50; Valium; Veramist Nasal Spray; Percocet; Phenergan; Exforge; Clonidine; Meclizine; Ventolin; Prozac; Neurontin; Spironolactone; Zoloft; Lisinopril; Cardovil; Reglan; Restoril; Lasix; Nexium; Skelaxin; Ondansetron HCL; Xanax

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017